This is the authors' abstract. We don't add key points for this paper.
Background and Aims Mild cognitive impairment (MCI) is prevalent in elderly individuals with type 2 diabetes, accelerating dementia risk due to metabolic dysregulation and neuroinflammation. Existing interventions for cognitive enhancement in this high‐risk group are limited. The aim of this study is to investigate the effect of computer‐based cognitive rehabilitation on cognitive function in elderly people with diabetes and MCI. Methods The Diabetes Research Center in Yazd, Iran, will provide 66 individuals between the ages of 60 and 75 for this randomized controlled experiment. Participants will be randomized to either the control group or the intervention group, which will receive 8 sessions of computer‐based cognitive training once a week. The Montreal Cognitive Assessment (MoCA), N‐Back, Stroop, and Go/No‐Go tests will be used to measure working memory, inhibitory control, selective attention, and general cognition both before and after the intervention. Using SPSS v 26, Statistical analyses will include ANCOVA, paired and independent t ‐tests (or non‐parametric equivalents), with significance set at p < 0.017 for the three primary outcomes after Bonferroni correction. All tests are two‐sided. Results It is hypothesized that participants in the intervention group will demonstrate greater improvements in working memory, selective attention, and inhibitory control compared with the control group. It is also expected that overall cognitive function, as shown by MoCA scores, will improve. Conclusion The effect of computer‐based cognitive rehabilitation on specific cognitive functions of older adults with diabetes and MCI will be evaluated in this randomized controlled trial. This intervention could have a beneficial effect on slowing the course of dementia in this high‐risk group if it proves to be effective. Future studies with longer follow‐up are recommended to confirm whether these effects are sustained. Trial Registration: Iranian Registry of Clinical Trials (IRCT20240505061658N1–Date: March 16, 2025).
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Ahadi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: